PATENT CLAIM ANALYSIS

Application Number: 16133918
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-01
Patent Classification: ["540", "546000"]

Abstract:
The present invention relates to inhibitors of zinc-dependent histone deacetylases (HDACs) useful in the treatment of diseases or disorders associated with HDAC6, having a Formula I: where R, L, X 1 , X 2 , X 3 , X 4 , Y 1 , Y 2 , Y 3 , and Y 4  are described herein.

Claim (Index 46):
The compound of  claim 45 , wherein the compound is of the Formula IA-2: or a pharmaceutically acceptable salt thereof.

Metadata:
- Claim Count in Document: 8.0
- Percentile: 97.0
- Lexical Diversity: 1.46512
- Patent Class: 540.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['16133922', '15013826', '15013820', '15013816', '15013814']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7560452005984908
- 35 USC 102 Novelty (BERT): 0.5594816412581358
- Combined Prediction Score: 0.7363888446644553
- Mean Citation Score: 421.88310200000006
- Max Citation Score: 436.4330000000001
- Similarity Product: 329.4605049527884

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test